SCHEMBL24012223

SCHEMBL24012223

CC(C)(C)OC(=O)N1CC(F)(F)C[C@@H]1C(=O)Nc1cc(C(N)(CCC2CC2)c2ccncc2)ccc1F

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ KLKB1 P03952 20/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24569826 0.90 KLKB1 (0.57) KLKB1
SCHEMBL24012212 0.89 KLKB1 (0.54) KLKB1
SCHEMBL24569877 0.89 KLKB1 (0.54) KLKB1
SCHEMBL24011969 0.87 KLKB1 (0.64) KLKB1
SCHEMBL31456810 0.87 KLKB1 (0.43) KLKB1
SCHEMBL20446630 0.86 KLKB1 (0.43) KLKB1
SCHEMBL29489482 0.86 KLKB1 (0.43) KLKB1
SCHEMBL20584479 0.86 KLKB1 (0.43) KLKB1
SCHEMBL24012200 0.86 KLKB1 (0.56) KLKB1
SCHEMBL24570715 0.85 KLKB1 (0.70) KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4019022-A1 HUMAN PLASMA KALLIKREIN INHIBITORS BioCryst Pharmaceuticals, Inc. (US) 2022-06-29 — — EP disclosed
EP-3355890-B1 HUMAN PLASMA KALLIKREIN INHIBITORS BIOCRYST PHARM INC (US) 2021-11-10 — — EP disclosed
Send feedback